Subject: Late Day Rally for CEYY Up 8.33%

SCV Client Spotlight
As more and more markets see the airing of The Doctors talk show where the Start Fresh Recovery Program was featured as a potential cure for alcoholism, the action in the stock is heating up!
Hot Stock to WatchHot Stock to Watch

Company: Fresh Start Private Management Inc. (OTCQB: CEYY)


Price: 0.13

Change (%): + 0.01 (8.33)

Volume: 217,843

Recent News

Fresh Start Private Management, Inc. Announces Appearance on the Emmy® Award-Winning Show, THE DOCTORS

LOS ANGELES, CA-(Marketwired - Jan 21, 2014) - Fresh Start Private Management, Inc. (OTCQB: CEYY) announces that Jeremy Miller, star of the former hit TV show Growing Pains and Dr. Fallieras, medical director at Start Fresh Recovery will appear on the Emmy® Award-winning nationally syndicated daytime talk show, THE DOCTORS. The episode is scheduled to air tomorrow, January 22nd (check local listings). Jeremy is a successful graduate of the company’s revolutionary alcohol treatment program that includes a specially formulated surgical implant of the drug Naltrexone that significantly reduces physical cravings for alcohol, coupled with a private coaching program specifically tailored to address the mental aspect of the addiction. Jeremy now works as a patient advocate at Start Fresh Recovery which uses the program developed by Fresh Start Private. They will be on the show to discuss how the program is being used to treat a patient named Todd who will also appear as a guest. The show will feature Todd’s life before he entered the program, followed by his actual implant procedure. Then viewers will witness how his life has dramatically changed when he appears to the live studio audience. A clip from the episode will be available after airing at

“I can’t tell you how proud we are of Todd’s courage to tell his story on national television. That takes guts, and hopefully his consent to air footage of his rock bottom to the world, followed by his amazing transformation will give hope to countless others,” said Brady Granier, COO of Fresh Start Private.

About Fresh Start Private (Soon to be BioCorRx, Inc.)

Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two components used by alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, visit

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks